Adaptive and Compensatory Mechanisms of the Cardiovascular System and
Disease Risk Factors in Young Males and Females

Basheer      Abdullah Marzoog

Abstract

Background: Cardiovascular disease (CVD) is increasing dramatically in young people and is the leading cause of death worldwide.

Aims: This study aimed to evaluate differences in the adaptive and compensatory mechanisms of the cardiovascular system (CVS) in young men and women to determine the most significant risk factors and assess the stability of the non-invasive method used in the early detection of CVD risk factors in young people.

Objectives: Currently, early evaluation of CVD risk factors is possible only through invasive methods, such as the Framingham risk score and the SCORE chart. Therefore, the development of a more flexible and non-invasive method is crucial in large populations.

Methods: A cohort cross-sectional investigation examined 173 volunteers, divided into two groups according to gender (n1 female=83, n2 male=90), and their heart rate, blood pressure (SBP/DBP), height, weight, and waist and hip circumference were non-invasively measured. Then, the potential adaptation value (R.M. Baevsky et al., 1987), Martinet test (MT), body mass index (BMI), and waist/hip ratio were calculated. Moreover, we collected information on lifestyle risk factors, including tobacco smoking, alcohol consumption, factors related to unhealthy diet, lack of physical activity, sleep deprivation, and anxiety, through special in-person interviews using paper/online questionnaires. The T-test and the x2 tests were applied for statistical analysis.

Results: Impaired/pathological cardiovascular adaptation was observed in 11.54% of the female group and 46.07% of the male group. In the female group, cardiovascular recovery abnormalities were observed in the SBP, DBP, and HR MT in 20.59%, 16.18%, and 44.12%, respectively, whereas in the male group, 32.50%, 21.25% and 36.25%, respectively. Despite gender, these deviations were accompanied by the prevalence of sympathetic influences in the regulation of CVS functions in 72.73% of the first group and 69.66% of the second group. BMI was violated in 47.19% of males and 29.49% of females. The test results were identical to that in the invasive methods of assessment of CVD risk factors.

Conclusion: Abnormalities in cardiovascular adaptation mechanisms in young women are less pronounced. Gender-dependent risk factors have high yields, such as obesity, low physical activity, and hypertension, which are more pronounced in men. The usability of the test requires further investigation on a larger sample.

Keywords: Cardiovascular and adaptation, Risk factor and physiopathology, Kerdo index, Obesity and lifestyle, Martinet’s test, Death.

[1]
Cardiovascular diseases (CVDs).  Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (Accessed on: Apr 16, 2021).

[2]
Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and stroke statistics—2019 update: A report from the American heart association. Circulation  2019; 139(10): e56-e528.
 [http://dx.doi.org/10.1161/CIR.0000000000000659] [PMID: 30700139]

[3]
Wang Z, Yu B. Metabolomics, proteomics, and genomics.Biomarkers in Cardiovascular Disease.  Elsevier 2019; pp. 159-70.
 [http://dx.doi.org/10.1016/B978-0-323-54835-9.00015-6]

[4]
Stein R, Ferrari F, Scolari F. Genetics, dyslipidemia, and cardiovascular disease: New insights. Curr Cardiol Rep  2019; 21(8): 68.
 [http://dx.doi.org/10.1007/s11886-019-1161-5] [PMID: 31227920]

[5]
Singh V, Watson RR. Lifestyle features and heart disease.Lifestyle in Heart Health and Disease.  Elsevier 2018; pp. 223-6.
 [http://dx.doi.org/10.1016/B978-0-12-811279-3.00017-3]

[6]
Srour B, Fezeu LK, Kesse-Guyot E, et al. Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Santé). BMJ  2019; 365: l1451.
 [http://dx.doi.org/10.1136/bmj.l1451] [PMID: 31142457]

[7]
Choi S, Kim K, Kim SM, et al. Association of obesity or weight change with coronary heart disease among young adults in South Korea. JAMA Intern Med  2018; 178(8): 1060-8.
 [http://dx.doi.org/10.1001/jamainternmed.2018.2310] [PMID: 29913019]

[8]
Chomistek AK, Cook NR, Rimm EB, Ridker PM, Buring JE, Lee IM. Physical activity and incident cardiovascular disease in women: is the relation modified by level of global cardiovascular risk? J Am Heart Assoc  2018; 7(12): e008234.
 [http://dx.doi.org/10.1161/JAHA.117.008234] [PMID: 29895589]

[9]
Reiner IC, Tibubos AN, Werner AM, et al. The association of chronic anxiousness with cardiovascular disease and mortality in the community: Results from the Gutenberg Health Study. Sci Rep  2020; 10(1): 12436.
 [http://dx.doi.org/10.1038/s41598-020-69427-8] [PMID: 32709910]

[10]
Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers  2019; 5(1): 56.
 [http://dx.doi.org/10.1038/s41572-019-0106-z] [PMID: 31420554]

[11]
Pol T, Held C, Westerbergh J, et al. Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with oral anticoagulation therapy: Insights from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial. J Am Heart Assoc  2018; 7(3): e007444.
 [http://dx.doi.org/10.1161/JAHA.117.007444] [PMID: 29419390]

[12]
Hedayatnia M, Asadi Z, Zare-Feyzabadi R, et al. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis  2020; 19(1): 42.
 [http://dx.doi.org/10.1186/s12944-020-01204-y] [PMID: 32178672]

[13]
Karlsen HR, Saksvik-Lehouillier I, Stone KL, Schernhammer E, Yaffe K, Langvik E. Anxiety as a risk factor for cardiovascular disease independent of depression: a prospective examination of community-dwelling men (the MrOS study). Psychol Health  2021; 36(2): 148-63.
 [http://dx.doi.org/10.1080/08870446.2020.1779273] [PMID: 32584189]

[14]
Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health  1951; 41(3): 279-86.
 [http://dx.doi.org/10.2105/AJPH.41.3.279] [PMID: 14819398]

[15]
Govindaraju DR, Adrienne AL, Kannel WB, et al. Genetics of the framingham heart study population. Adv Genet  2008; 62: 33-65.
 [http://dx.doi.org/10.1016/S0065-2660(08)00602-0]

[16]
Splansky GL, Corey D, Yang Q, et al. The Third generation cohort of the national heart, lung, and blood institute’s framingham heart study: Design, recruitment, and initial examination. Am J Epidemiol  2007; 165(11): 1328-35.
 [http://dx.doi.org/10.1093/aje/kwm021] [PMID: 17372189]

[17]
Keys A, Menotti A, Aravanis C, et al. The seven countries study: 2,289 deaths in 15 years. Prev Med  1984; 13(2): 141-54.
 [http://dx.doi.org/10.1016/0091-7435(84)90047-1] [PMID: 6739443]

[18]
Cybulska B, Kłosiewicz-Latoszek L. Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years. Kardiol Pol  2019; 77(2): 173-80.
 [http://dx.doi.org/10.5603/KP.a2019.0017] [PMID: 30828782]

[19]
Alves DGL, Rocha SG, Andrade EV, Mendes AZ, Cunha ÂGJ. The positive impact of physical activity on the reduction of anxiety scores: a pilot study. Rev Assoc Med Bras  2019; 65(3): 434-40.
 [http://dx.doi.org/10.1590/1806-9282.65.3.434] [PMID: 30994844]

[20]
Spielberger anxiety test.  Available from: https://psycho-tests.com/test/spielberger-anxiety-test

[21]
Chmielewski J. [Simplified Method of Evaluating Martinet’s Test for Mass Studies of the Functional State of the Cardiovascular System]. Kardiologiia  1970; 10(9): 145.
 [PMID: 5501505]

[22]
Roy A, Rawal I, Jabbour S, Prabhakaran D. Tobacco and cardiovascular disease: A summary of evidence. In: Cardiovascular, Respiratory, and Related Disorders.  (3rd edition.), Washington (DC): The International Bank for Reconstruction and Development / The World Bank 2017.
 [http://dx.doi.org/10.1596/978-1-4648-0518-9_ch4] [PMID: 30212086]

[23]
Banks E, Joshy G, Korda RJ, et al. Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study. BMC Med  2019; 17(1): 128.
 [http://dx.doi.org/10.1186/s12916-019-1351-4] [PMID: 31266500]

[24]
Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension  2020; 75(2): 285-92.
 [http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14240] [PMID: 31865786]

[25]
Gijsen F, Katagiri Y, Barlis P, et al. Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications. Eur Heart J  2019; 40(41): 3421-33.
 [http://dx.doi.org/10.1093/eurheartj/ehz551] [PMID: 31566246]

[26]
Wengrofsky P. Dyslipidemia and its role in the pathogenesis of atherosclerotic cardiovascular disease: Implications for evaluation and targets for treatment of dyslipidemia based on recent guidelines. In: Dyslipidemia. IntechOpen 2019.
 [http://dx.doi.org/10.5772/intechopen.85772]

[27]
Li J, Lee DH, Hu J, et al. Dietary inflammatory potential and risk of cardiovascular disease among men and women in the U.S. J Am Coll Cardiol  2020; 76(19): 2181-93.
 [http://dx.doi.org/10.1016/j.jacc.2020.09.535] [PMID: 33153576]

[28]
Bucholz EM, Gooding HC, de Ferranti SD. Awareness of cardiovascular risk factors in U.S. young adults aged 18–39 years. Am J Prev Med  2018; 54(4): e67-77.
 [http://dx.doi.org/10.1016/j.amepre.2018.01.022] [PMID: 29433955]

[29]
Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr  2017; 9(1): 25.
 [http://dx.doi.org/10.1186/s13098-017-0225-1] [PMID: 28435446]

[30]
Jeong SM, Choi S, Kim K, et al. Effect of change in total cholesterol levels on cardiovascular disease among young adults. J Am Heart Assoc  2018; 7(12): e008819.
 [http://dx.doi.org/10.1161/JAHA.118.008819] [PMID: 29899019]

[31]
Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol Heart Circ Physiol  2018; 315(6): H1569-88.
 [http://dx.doi.org/10.1152/ajpheart.00396.2018] [PMID: 30216121]

[32]
Ciffone NA, Copple T. Managing dyslipidemia for CVD prevention. Nurse Pract  2019; 44(1): 8-16.
 [http://dx.doi.org/10.1097/01.NPR.0000550246.96902.de] [PMID: 30531203]

[33]
Zhang X, Cash RE, Bower JK, Focht BC, Paskett ED. Physical activity and risk of cardiovascular disease by weight status among U.S adults. PLoS One  2020; 15(5): e0232893.
 [http://dx.doi.org/10.1371/journal.pone.0232893] [PMID: 32384119]